Rhenman & Partners Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-310,000
| Closed | -$3.85M | – | 92 |
|
|
2022
Q2 | $3.85M | Buy |
310,000
+60,700
| +24% | +$754K | 0.44% | 61 |
|
|
2022
Q1 | $3.32M | Sell |
249,300
-700
| -0.3% | -$9.33K | 0.33% | 74 |
|
|
2021
Q4 | $4.02M | Hold |
250,000
| – | – | 0.27% | 79 |
|
|
2021
Q3 | $5.61M | Hold |
250,000
| – | – | 0.39% | 70 |
|
|
2021
Q2 | $5.69M | Buy |
250,000
+25,000
| +11% | +$569K | 0.39% | 77 |
|
|
2021
Q1 | $4.63M | Buy |
225,000
+25,000
| +13% | +$515K | 0.32% | 76 |
|
|
2020
Q4 | $5.52M | Sell |
200,000
-180,000
| -47% | -$4.97M | 0.45% | 65 |
|
|
2020
Q3 | $5.34M | Buy |
380,000
+230,000
| +153% | +$3.23M | 0.47% | 62 |
|
|
2020
Q2 | $3.09M | Buy |
+150,000
| New | +$3.09M | 0.33% | 75 |
|